the CEO of NewBridge Pharmaceuticals Interview with TBY

The Business Year talks to Joe Henein, President and CEO of NewBridge Pharmaceuticals, on the global pharmaceuticals market, innovation, and the perception of the GCC market for overseas investors. https://www.thebusinessyear.com/dubai-2020/joe-henein-ceo-new-bridge-pharmaceuticals/vip-interview

the CEO of NewBridge Pharmaceuticals Interview with CNBC

Watch CNBC Arabia’s episode “Made in UAE” Documentary featuring Joe Henein, President and CEO of NewBridge Pharmaceuticals, and his colleagues talk about NewBridge’s Journey on its 10th year anniversary, highlighting…

CAPHOSOL® CAPHOSOL DISPERSIBLE®

Description Caphosol® is indicated for the treatment and prevention of oral mucositis, a complication of cancer treatment (including radiation and chemotherapy). It contains a high concentration of phosphate and calcium…

Latuda

Name LATUDA® (Lurasidone) Description LATUDA® is a once-daily oral atypical antipsychotic. In addition to its well-demonstrated efficacy, LATUDA® with its favorable metabolic safety profile may be a solution for unmet…

COLLATAMP

Guardant360

Description Guardant360® assay is a liquid biopsy that provides fast, accurate and comprehensive genomic results from a simple blood draw. Test results are available in approximately seven days upon receipt…

NewBridge Pharmaceuticals -2018 winner of the Most Innovative Pharmaceutics Commercialisation Partner MENA award

“The www.CFI.co judging panel applauds the company’s mission to address unmet medical needs in the MENA region through strategic joint-ventures and partnerships, naming NewBridge Pharmaceuticals the 2018 winner of the…

NewBridge Pharmaceuticals at WCO-IOF-ESCEO Paris 2019

Joe Henein, the President & CEO of NewBridge Pharmaceuticals, Sherif Hamdy Franchise Head Metabolic Care and Lina Sabbagh Commercial Lead CNS Lebanon attended the World Congress on Osteoporosis, Osteoarthritis and…

NewBridge Pharmaceuticals at EASL 2019

NewBridge President and CEO Joe Henein, Business Director Group Franchise Hisham EL Sayed and Brand Manager Rare Diseases Jennifer Bteich, attended The International Liver Congress “EASL 2019”, that was held…

Multiple Products, Multiple Geographies

TBY talks to Joe Henein, CEO of NewBridge Pharmaceuticals, on building brands, supporting SMEs in the region, and driving innovation. To read more, click on this link. Source Article: thebusinessyear…